Suction catheter assemblies

Abstract: A closed system suction catheter assembly has a protective sleeve 2 enclosing an aspirating catheter 1 extending though a sliding seal 50 in a patient coupling 4. The catheter 1 has an antimicrobial surface such as formed by silver sulfadiazine which reduces the accumulation of bacteria and prolongs the useful life of the assembly.

Description: This invention relates to suction catheter assemblies of the kind for use in removing undesirable fluid from the respiration passages of a patient, the catheter assembly including an aspirating catheter having a proximal end and a distal end suitable for insertion into a patient, a vacuum coupling located in the vicinity of the proximal end of the aspirating catheter, a patient coupling mounted to surround the aspirating catheter in the vicinity of the distal end of the aspirating catheter, and a flexible protective sleeve extending along the aspirating catheter where it extends between the patient coupling and the vacuum coupling , and the patient coupling having a sliding seal with the external surface of the aspirating catheter such that the catheter is wiped by the seal as it is advanced into the patient and withdrawn periodically through the sliding seal into the protective envelope. In such assemblies the patient coupling has one port connected to a tracheal tube and two further side ports by which ventilation of the patient can take place. In use, the machine end of the catheter is connected to a suction source via a valve. Secretions that build up on the inside of the tracheal tube, the trachea and bronchi can be periodically removed by advancing the catheter through the coupling and down the tracheal tube and opening the valve. The coupling enables ventilation of the patient to continue while suctioning takes place. Examples of catheter assemblies having an aspirating catheter which is contained within a sleeve and which can be pushed through a sliding seal on a coupling are described in several patents, such as US 3,991,752 to Radford; US 4,569,344 to Palmer; US 4,638,539 to Palmer; US 4,696,296 to Palmer; US 4,825,859 to Lambert; US 4,834,726 to Lambert; US 4,836,199 to Palmer; US 4,838,255 to Lambert; US 4,872,579 to Palmer; US 4,938,741 to Lambert; US 4,967,743 to Lambert; US 4,981,466 to Lambert; US 5,025,806 to Palmer; US 5,029,580 to Radford; US 5,060,646 to Page; US 5,065,754 to Jensen; and GB 2207736 to Hollister. US 5,073,164 to Hollister describes a suction catheter corresponding to the preamble of the main claim of the present application. Suction catheter assemblies of this kind are also available from Smiths Industries Medical Systems Inc under the trade mark STERICATH and from Ballard Medical Products Inc under the trade mark TRACHCARE. The sliding seal in the assembly removes some of the secretions clinging to the outside of the aspirating catheter each time it is withdrawn but, nevertheless, some will remain on the external surface of the catheter. These secretions contain microbes from the patient that can colonize to larger populations and present a potential risk to the patient on reintroduction of the catheter. In some assemblies, irrigating fluid can be applied to the outside of the catheter which helps remove secretions but does not completely remove them. The environment within the protective sleeve encourages the multiplication of bacteria on the outside of the catheter and, for this reason, the time for which the suction catheter assembly can be used is generally limited to about 24 hours. This is a disadvantage because each time the assembly has to be removed and replaced, ventilation of the patient must be interrupted. The opening of the ventilation circuit can allow external microbes to be introduced into the patient causing nosocomial infections. Also, the repeated replacement of the assemblies leads to increased cost and waste, with the consequent disposal difficulties involved with soiled surgical products. Closed system suction catheter assemblies have considerable advantages to the user compared with conventional suction catheters so it is highly desirable for the cost of using the assemblies to kept as low as possible in order to encourage their use. Any assembly which can be used safely for a longer period would, therefore, bring with it cost savings and advantages to the patient. DE-A-3435553 describes external breathing tubing having a bactericidal surface to enable prolonged use of the tubing by reducing the build up of contaminants as a result of handling. It is an object of the present invention to provide a closed-system suction catheter assembly which can be used for a longer period. According to the present invention there is provided a tracheal suction catheter assembly of the above-specified kind, characterised in that the aspirating catheter has at least an external surface with antimicrobial properties that remain effective after wiping by the seal and that minimize the accumulation of bacteria on the external surface of the catheter while the catheter is withdrawn in the protective sleeve. The antimicrobial surface is preferably provided by an antimicrobial substance incorporated within the wall of the catheter. Alternatively, an antimicrobial coating could be formed by a coating on the external surface of the catheter. The antimicrobial surface may be provided by a substance including a silver compound such as silver sulfadiazine. The antimicrobial substance may include a silver compound with a binder such as alumino-silicate or hydroxyapitate. Alternatively, the antimicrobial substance may include a silver compound with a polymer attachment substance. The antimicrobial substance may include chlorhexidene. The aspirating catheter may be substantially of PVC. It has previously been proposed to coat catheters which remain in the body for prolonged periods with an antimicrobial substance so as to reduce the risk of infection. Examples of these previous catheters include urinary catheters and venous catheters (such as the Arrow Antiseptic Multi-Lumen Central Venous Catheter. "Arrow" is a Registered Trade Mark). These catheters remain in the body and are disposed of after use. By contrast, in the present invention the catheter remains outside the body for the majority of the time and is periodically inserted and removed through a sliding seal. It has been discovered that an antimicrobial surface on an aspirating catheter is effective to reduce the build up of bacteria outside the body and that the antimicrobial properties remain effective even though the catheter passes repeatedly through a sliding seal. A suction catheter assembly in accordance with the present invention, will now be described, by way of example, with reference to the accompanying drawings, in which: Figure 1 is a perspective view of the assembly; and Figure 2 is a sectional view of the assembly; to a larger scale. The suction catheter assembly comprises an aspirating catheter 1 that extends within a flexible, protective sleeve 2 between a vacuum connecting member 3 and a patient connecting member 4. The aspirating catheter 1 has an outside diameter of about 4-5mm and a length of about 55cm. In the illustrated example, the catheter 1 has a single lumen 10 although catheters with multiple lumens for use in irrigation, oxygen supply or medication delivery could be used. At its machine or proximal end, the catheter 1 is secured to the vacuum connecting member 3. The vacuum connecting member 3 is moulded from a rigid plastics material and has a bore (not shown) extending along it into one end of which the catheter 1 is bonded. The opposite end of the bore extends through a spigot 31 which, in use, is connected to tubing 5 which extends to a vacuum or suction source 6. The vacuum connecting member 3 includes a conventional manually-operated valve 32 which normally prevents flow through the connecting member 3 and catheter 1 but which can be pressed down by the user to open the valve and connect the lumen 10 of the catheter to the suction source 6. The proximal end of the sleeve 2 is secured to the vacuum connecting member 3 beneath a threaded collar 33 secured to the distal end of the vacuum connecting member. The distal end of the sleeve 2 is similarly secured to the patient connecting member 4 by means of a threaded collar 43 which is screwed onto a threaded, proximal extension 44 of the patient connecting member. The patient connecting member 4 is of generally cruciform shape. At its distal, or patient end, the connecting member 4 has a female luer coupling 40 which is aligned with the axis of the member and with the proximal extension 44. The coupling 40 is adapted to be connected to a cooperating coupling 41 on the end of a tracheal tube 42. Two side ports 45 and 46 extend at right angles to the axis of the connecting member, directly opposite one another, about midway along the length of the connecting member. These two side ports 45 and 46 communicate directly with the interior of the coupling 40 and are used in the conventional manner to connect with ventilation apparatus. One port may be used for inhalation gas and the other port used for exhalation gas. Alternatively, one of the ports 46 may be closed by a cap 47 and inhalation and exhalation both be effected through the other port 45. The patient connecting member 4 includes a sliding seal 50 in the form of a resilient diaphragm with a central aperture 51 through which extends the aspirating catheter as a close sliding fit. The aspirating catheter 1 is mainly of PVC but contains an antimicrobial substance so that it has an external surface 11 which has antimicrobial properties. The antimicrobial substance is blended with polymer pellets, in a proportion of about 3-10% by weight substance to polymer, prior to extrusion of the catheter so that the wall of the catheter is antimicrobial throughout its thickness and has antimicrobial properties on both its internal and external surfaces. Alternatively, the external antimicrobial surface may be formed by coating or otherwise forming an antimicrobial layer on the external surface only. The antimicrobial substance may be silver sulfadiazine or chlorhexidine. Alternatively, a silver ion with a binder such as alumino-silicate, hydroxyapatite or a polymer attachment substance such as polyurethane could be used. Combinations of these materials, such as, silver sulfadizine and chlorhexidine could also be used. In operation, the coupling 40 of the connecting member 4 is secured to a coupling 41 on the end of a tracheal tube 42 and its side ports 45 and 46 are connected to a ventilator. The vacuum coupling member 3 is connected to the suction source 6 but, as long as the manual valve 32 remains unactuated, no suction is applied to the catheter 1. When aspiration of fluid from the trachea or bronchi is required, the user grips the catheter 1 through the sleeve 2 and pushes it forwardly so that the distal, patient end of the catheter is advanced through the connecting member 4 and into the tracheal tube 42. When the catheter 1 has been inserted to the desired depth, the user depresses the valve 32 so that the catheter is connected to the suction source 6 and fluid in the vicinity of the tip of the catheter is sucked into the catheter and removed. During aspiration, ventilation of the patient occurs normally. When aspiration is complete, the catheter 1 is pulled back into the sleeve 2, the assembly remaining attached to the tracheal tube connector so that it can be reused when necessary. It has been found that the antimicrobial properties of the external surface 11 remain effective for a prolonged period despite being repeatedly displaced backwards and forwards through the sliding seal 50. The antimicrobial surface 11 minimizes the growth of bacteria on the catheter and enables the assembly to be used for periods of up to about 48 hours depending on how frequently the assembly is used. This is considerably longer than an equivalent assembly without any antimicrobial treatment which might typically be used for about 24 hours. Alternative assemblies may include an antimicrobial substance on further components of the assembly that is effective to reduce transfer of bacteria from the catheter to the patient. For example, an antimicrobial substance on the inside of the sleeve 2 may help reduce microbial accumulation on the external surface of the catheter because of contact of the sleeve with the catheter during handling. In addition, an antimicrobial substance in the sliding seal 50 might help reduce transfer of bacteria from the catheter to the patient as the catheter is pushed through the seal.

Claims: A tracheal closed-system suction catheter assembly for use in removing undesirable fluid from the respiration passages of a patient, the catheter assembly including an aspirating catheter (1) having a proximal end and a distal end suitable for insertion into a patient, a vacuum coupling (3) located in the vicinity of the proximal end of the aspirating catheter (1), a patient coupling (4) mounted to surround the aspirating catheter (1) in the vicinity of the distal end of the aspirating catheter (1), and a flexible protective sleeve (2) extending along the aspirating catheter (1) where it extends between the patient coupling (4) and the vacuum coupling (3), and the patient coupling (4) having a sliding seal (50) with the external surface (11) of the aspirating catheter (1) such that the catheter (1) is wiped by the seal (50) as it is advanced into the patient and withdrawn periodically through the sliding seal (50) into the protective envelope (2), characterised in that the aspirating catheter (1) has at least an external surface (11) with antimicrobial properties that remain effective after wiping by the seal (50) that minimize the accumulation of bacteria on the external surface of the catheter (1) while the catheter is withdrawn in the protective sleeve (2). A suction catheter assembly according to Claim 1, characterised in that the antimicrobial surface is provided by an antimicrobial substance incorporated within the wall of the catheter (1). A suction catheter assembly according to Claim 1, characterised in that the antimicrobial surface is provided by a coating on the external surface (11) of the catheter (1). A suction catheter assembly according to any one of the preceding claims, characterised in that the antimicrobial surface is provided by a substance including a silver compound. A suction catheter assembly according to Claim 4, characterised in that the antimicrobial substance includes silver sulfadiazine. A suction catheter assembly according to Claim 4 or 5, characterised in that the antimicrobial substance includes a silver compound with a binder. A suction catheter assembly according to Claim 6, characterised in that the binder is selected from the group comprising alumino-silicate and hydroxyapatite. A suction catheter assembly according to Claim 4 or 5, characterised in that the antimicrobial substance includes a silver compound with a polymer attachment substance. A suction catheter assembly according to any one of the preceding claims, characterised in that the antimicrobial substance includes chlorhexidene.

Inventors: BELL CRAIG, HOLLISTER WILLIAM, BELL, CRAIG, HOLLISTER, WILLIAM
Applicants: SMITHS IND MED SYST INC, SMITHS INDUSTRIES MEDICAL SYSTEMS INC.
Application year: 1993
Main classification: A61M16
IPC codes: A61L29, A61M16, A61M1, A61M25